- Prediction of the Duration to Next Admission for an Acute Affective Episode in Patients with Bipolar I Disorder
-
Chen PH, Shih CM, Chang CK, Lin CP, Chang YH, Lee HC, Loh EW
- KMID: 2542933
- Clin Psychopharmacol Neurosci.
- 2023 May;21(2):262-270.
- doi: 10.9758/cpn.2023.21.2.262
Objective: Predicting disease relapse and early intervention could reduce symptom severity. We attempted to identify potential indicators that predict the duration to next admission for an acute affective episode in... -
- CITED
-
- Close
- SHARE
-
- Close
- Effectiveness of N-acetylcysteine in Treating Clinical Symptoms of Substance Abuse and Dependence: A Meta-analysis of Randomized Controlled Trials
-
Chang CT, Hsieh PJ, Lee HC, Lo CH, Tam KW, Loh EW
- KMID: 2516180
- Clin Psychopharmacol Neurosci.
- 2021 May;19(2):282-293.
- doi: 10.9758/cpn.2021.19.2.282
Objective: Treatment with N-acetylcysteine (NAC) is believed to reduce the clinical symptoms among individuals with substance abuse or dependence. We conducted a meta-analysis of randomized controlled trials to evaluate the... -
- CITED
-
- Close
- SHARE
-
- Close
- Association of the PPAR-gamma Gene with Altered Glucose Levels and Psychosis Profile in Schizophrenia Patients Exposed to Antipsychotics
-
Liu YR, Hu TM, Lan TH, Chiu HJ, Chang YH, Chen SF, Yu YH, Chen CC, Loh EW
- KMID: 1994609
- Psychiatry Investig.
- 2014 Apr;11(2):179-185.
- doi: 10.4306/pi.2014.11.2.179
OBJECTIVE: Metabolic abnormalities, e.g., diabetes, are common among schizophrenia patients. Peroxisome proliferator activated receptor-gamma (PPAR-gamma) regulates glucose/lipid metabolisms, and schizophrenia like syndrome may be induced by actions involving retinoid X... -
- CITED
-
- Close
- SHARE
-
- Close
